The National Institutes of Health said today that it’s launching a huge research study with the aim of making precision medicine available to people of all backgrounds.
Background: President Obama first announced the program back in 2015 to realize the dream of precision medicine—that is, tailoring health care to an individual’s genetics, lifestyle, and environment. It’s been in beta testing for the past year, and so far about 25,000 participants have joined.
Diverse data: In a briefing with reporters, NIH officials said they are focusing on gathering health and genetic data from diverse and historically underrepresented groups—including ethnic and sexual minorities, as well as people with disabilities, with less than a high school education, and with income below the poverty level. NIH is hosting events in diverse communities around the country to sign people up.
Next steps: Dubbed All of Us, the program will begin sequencing participants’ genomes later this year. The goal is to enroll a million participants who will share health information about themselves, through means including surveys and electronic health records, with researchers over the 10 years of the program.
Biotechnology and health
Scientists are finding signals of long covid in blood. They could lead to new treatments.
Faults in a certain part of the immune system might be at the root of some long covid cases, new research suggests.
This baby with a head camera helped teach an AI how kids learn language
A neural network trained on the experiences of a single young child managed to learn one of the core components of language: how to match words to the objects they represent.
The first gene-editing treatment: 10 Breakthrough Technologies 2024
Sickle-cell disease is the first illness to be beaten by CRISPR, but the new treatment comes with an expected price tag of $2 to $3 million.
Weight-loss drugs: 10 Breakthrough Technologies 2024
Weight-loss drugs like Wegovy and Mounjaro are wildly popular and effective, but their long-term health impacts are still unknown.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.